Neumann-Mufweba, A. et al. 2022. The diaryl-imidazopyridazine anti-plasmodial compound, MMV652103, exhibits anti-breast cancer activity. EXCLI Journal. 21, (Apr. 2022), 656–679. DOI:https://doi.org/10.17179/excli2021-4323.